In the study by Abe et al., the authors evaluated ARID1A loss in EBV-associated gastric carcinoma, by performing in situ hybridization of EBV-encoded RNA and immunohistochemistry of ARID1A in non-neoplastic gastric mucosa and intramucosal cancer tissue [77]. Here, ARID1A is linked to cancer.